ResearcherShuguang HospitalNo recent work listed

Xiaoting Sun

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0003-0622-8092; OpenAlex author ID A5048026130.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. First author DOI 10.1136/gutjnl-2020-322744 ↗
p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fonc.2019.01294 ↗

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Xingkang He · 1 shared paper, 2022
- Paper Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer esc… DOI 10.1136/gutjnl-2020-322744 ↗
Yihai Cao · 1 shared paper, 2022
- Paper Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer esc… DOI 10.1136/gutjnl-2020-322744 ↗
Qi Li · 1 shared paper, 2022
- Paper Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer esc… DOI 10.1136/gutjnl-2020-322744 ↗
Ling Yang · 1 shared paper, 2019
- Paper p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. DOI 10.3389/fonc.2019.01294 ↗
Shun Ni Zhu · 1 shared paper, 2019
- Paper p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. DOI 10.3389/fonc.2019.01294 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.